Merck & Co., Inc.
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30250% above fair value
$149.52+3.19 (+2.18%)
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Sales by Subsidiaries Outside the United States
Sales by Subsidiaries Outside the United States (% of Consolidated Sales) (%)
Merck Sales by Subsidiaries Outside the United States: 44.0% in FY2025, down 6.0 pts from a year earlier.
Latest, FY2025
44.0%
Period ended Dec 31, 2025
Change on a year earlier
-6.0 pts
50.0% in FY2024
History
3 years
Since FY2023
Sources
1
Form 10-K (mrk-20251231.htm, filed 2026-02-24)
Where the FY2025 figure comes from
“Sales worldwide by subsidiaries outside the U.S. as a percentage of total Company sales were 44% in 2025, 50% in 2024 and 53% in 2023.”
Source: Form 10-K (mrk-20251231.htm, filed 2026-02-24) ↗
Reported in Form 10-K Item 1 Business.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Sales by Subsidiaries Outside the United States (% of Consolidated Sales) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 44.0% | -6.0 pts | Form 10-K (mrk-20251231.htm, filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 50.0% | -3.0 pts | Form 10-K (mrk-20251231.htm, filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 53.0% | – | Form 10-K (mrk-20251231.htm, filed 2026-02-24) ↗ |
Cite this data
StockData. (2026). Merck Sales by Subsidiaries Outside the United States (%), annual FY2023–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-nonus-sub-share
See every metric in the Merck KPI table. Data updated Oct 26, 2026.